Annual Total Expenses
$49.26 M
+$17.01 M+52.74%
December 31, 2023
Summary
- As of February 7, 2025, CAPR annual total expenses is $49.26 million, with the most recent change of +$17.01 million (+52.74%) on December 31, 2023.
- During the last 3 years, CAPR annual total expenses has risen by +$35.26 million (+251.82%).
- CAPR annual total expenses is now at all-time high.
Performance
CAPR Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$15.27 M
-$291.20 K-1.87%
September 30, 2024
Summary
- As of February 7, 2025, CAPR quarterly total expenses is $15.27 million, with the most recent change of -$291.20 thousand (-1.87%) on September 30, 2024.
- Over the past year, CAPR quarterly total expenses has dropped by -$291.20 thousand (-1.87%).
- CAPR quarterly total expenses is now -1.87% below its all-time high of $15.56 million, reached on June 30, 2024.
Performance
CAPR Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CAPR Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +52.7% | -1.9% |
| 3 y3 years | +251.8% | +69.2% |
| 5 y5 years | +189.8% | +69.2% |
CAPR Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +132.5% | -1.9% | +139.4% |
| 5 y | 5-year | at high | +463.6% | -1.9% | +795.4% |
| alltime | all time | at high | >+9999.0% | -1.9% | +7166.9% |
Capricor Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.27 M(-1.9%) |
| Jun 2024 | - | $15.56 M(+2.6%) |
| Mar 2024 | - | $15.17 M(+13.5%) |
| Dec 2023 | $49.26 M(+52.7%) | $13.37 M(+2.4%) |
| Sep 2023 | - | $13.05 M(+11.9%) |
| Jun 2023 | - | $11.66 M(+4.4%) |
| Mar 2023 | - | $11.17 M(+23.8%) |
| Dec 2022 | $32.25 M(+52.2%) | $9.03 M(+11.9%) |
| Sep 2022 | - | $8.07 M(+10.2%) |
| Jun 2022 | - | $7.32 M(-6.5%) |
| Mar 2022 | - | $7.83 M(+22.8%) |
| Dec 2021 | $21.18 M(+51.3%) | $6.38 M(+47.9%) |
| Sep 2021 | - | $4.31 M(-18.4%) |
| Jun 2021 | - | $5.29 M(+1.6%) |
| Mar 2021 | - | $5.20 M(+22.7%) |
| Dec 2020 | $14.00 M(+60.2%) | $4.24 M(+7.8%) |
| Sep 2020 | - | $3.93 M(+11.1%) |
| Jun 2020 | - | $3.54 M(+54.3%) |
| Mar 2020 | - | $2.29 M(+34.5%) |
| Dec 2019 | $8.74 M(-48.6%) | $1.71 M(-3.6%) |
| Sep 2019 | - | $1.77 M(-28.5%) |
| Jun 2019 | - | $2.48 M(-11.2%) |
| Mar 2019 | - | $2.79 M(-29.5%) |
| Dec 2018 | $17.00 M(+9.5%) | $3.95 M(-10.0%) |
| Sep 2018 | - | $4.39 M(-3.8%) |
| Jun 2018 | - | $4.57 M(+11.8%) |
| Mar 2018 | - | $4.09 M(+8.8%) |
| Dec 2017 | $15.53 M(-23.0%) | $3.76 M(+27.3%) |
| Sep 2017 | - | $2.95 M(-32.6%) |
| Jun 2017 | - | $4.38 M(-1.6%) |
| Mar 2017 | - | $4.45 M(+23.6%) |
| Dec 2016 | $20.17 M(+23.1%) | $3.60 M(-39.3%) |
| Sep 2016 | - | $5.92 M(+7.2%) |
| Jun 2016 | - | $5.52 M(+7.8%) |
| Mar 2016 | - | $5.12 M(+22.1%) |
| Dec 2015 | $16.39 M(+60.9%) | $4.20 M(+11.5%) |
| Sep 2015 | - | $3.76 M(-5.3%) |
| Jun 2015 | - | $3.97 M(-10.8%) |
| Mar 2015 | - | $4.46 M(+53.2%) |
| Dec 2014 | $10.18 M(+47.5%) | $2.91 M(+15.1%) |
| Sep 2014 | - | $2.53 M(+0.2%) |
| Jun 2014 | - | $2.52 M(+13.2%) |
| Mar 2014 | - | $2.23 M(-5.7%) |
| Dec 2013 | $6.90 M(+228.7%) | $2.36 M(+58.0%) |
| Sep 2013 | - | $1.49 M(-7.5%) |
| Jun 2013 | - | $1.62 M(+12.8%) |
| Mar 2013 | - | $1.43 M(-762.8%) |
| Dec 2012 | $2.10 M | -$216.10 K(-137.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $576.30 K(>+9900.0%) |
| Jun 2012 | - | $0.00(-100.0%) |
| Mar 2012 | - | $965.40 K(-48.1%) |
| Dec 2011 | $6.25 M(-0.6%) | $1.86 M(-5.5%) |
| Sep 2011 | - | $1.97 M(+60.6%) |
| Jun 2011 | - | $1.23 M(+2.4%) |
| Mar 2011 | - | $1.20 M(+14.8%) |
| Dec 2010 | $6.29 M(-20.2%) | $1.04 M(-42.5%) |
| Sep 2010 | - | $1.81 M(+20.8%) |
| Jun 2010 | - | $1.50 M(-22.5%) |
| Mar 2010 | - | $1.94 M(+22.8%) |
| Dec 2009 | $7.88 M(-41.2%) | $1.58 M(-21.9%) |
| Sep 2009 | - | $2.02 M(-19.3%) |
| Jun 2009 | - | $2.50 M(+40.0%) |
| Mar 2009 | - | $1.79 M(-40.4%) |
| Dec 2008 | $13.40 M(+39.6%) | $3.00 M(-11.2%) |
| Sep 2008 | - | $3.38 M(-12.3%) |
| Jun 2008 | - | $3.85 M(+21.2%) |
| Mar 2008 | - | $3.18 M(+16.8%) |
| Dec 2007 | $9.60 M(+233.5%) | $2.72 M(-42.6%) |
| Sep 2007 | - | $4.74 M(+231.9%) |
| Jun 2007 | - | $1.43 M(+99.7%) |
| Mar 2007 | - | $714.90 K(-24.5%) |
| Dec 2006 | $2.88 M(>+9900.0%) | $947.10 K(+20.6%) |
| Sep 2006 | - | $785.10 K(-8823.3%) |
| Jun 2006 | - | -$9000.00(-225.0%) |
| Mar 2006 | - | $7200.00(+1.4%) |
| Dec 2005 | $18.90 K(-0.5%) | $7100.00(+108.8%) |
| Sep 2005 | - | $3400.00(+17.2%) |
| Jun 2005 | - | $2900.00(-46.3%) |
| Mar 2005 | - | $5400.00(-47.1%) |
| Dec 2004 | $19.00 K(+3.8%) | $10.20 K(+191.4%) |
| Sep 2004 | - | $3500.00(+20.7%) |
| Jun 2004 | - | $2900.00(+16.0%) |
| Mar 2004 | - | $2500.00(-53.7%) |
| Dec 2003 | $18.30 K(-37.5%) | $5400.00(+134.8%) |
| Sep 2003 | - | $2300.00(-67.1%) |
| Jun 2003 | - | $7000.00(+89.2%) |
| Mar 2003 | - | $3700.00(-2.6%) |
| Dec 2002 | $29.30 K(+31.4%) | $3800.00(-55.8%) |
| Sep 2002 | - | $8600.00(-25.9%) |
| Jun 2002 | - | $11.60 K(+118.9%) |
| Mar 2002 | - | $5300.00(+89.3%) |
| Dec 2001 | $22.30 K(-38.9%) | $2800.00(-40.4%) |
| Sep 2001 | - | $4700.00(-16.1%) |
| Jun 2001 | - | $5600.00(-38.5%) |
| Mar 2001 | - | $9100.00 |
| Dec 2000 | $36.50 K(>+9900.0%) | - |
| Dec 1999 | $200.00 | - |
FAQ
- What is Capricor Therapeutics annual total expenses?
- What is the all time high annual total expenses for Capricor Therapeutics?
- What is Capricor Therapeutics annual total expenses year-on-year change?
- What is Capricor Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly total expenses year-on-year change?
What is Capricor Therapeutics annual total expenses?
The current annual total expenses of CAPR is $49.26 M
What is the all time high annual total expenses for Capricor Therapeutics?
Capricor Therapeutics all-time high annual total expenses is $49.26 M
What is Capricor Therapeutics annual total expenses year-on-year change?
Over the past year, CAPR annual total expenses has changed by +$17.01 M (+52.74%)
What is Capricor Therapeutics quarterly total expenses?
The current quarterly total expenses of CAPR is $15.27 M
What is the all time high quarterly total expenses for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly total expenses is $15.56 M
What is Capricor Therapeutics quarterly total expenses year-on-year change?
Over the past year, CAPR quarterly total expenses has changed by -$291.20 K (-1.87%)